ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lupin Limited ( (IN:LUPIN)) just unveiled ...
Classes are one of the many reasons why 99 Nights in the Forest has so much replayability. Each class has its own set of starter tools to change your gameplay, as well as level upgrades that will give ...
Public schools are canceling a class aimed at building the next generation of Latino leaders after pressure from the federal government. Florida districts received a letter from the U.S. Department of ...
Ever wonder where your income puts you compared to the rest of the country? I do. Not in a comparison-obsessed way, but more like a quick "Am I doing OK?" check-in kind of thing. The U.S. Census ...
Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...
WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...
Quiet In Class is a 3-part docuseries about how a predator was allowed to continue working at the Internationella Engelska Skolan (International English School) in Karlstad, Sweden, despite multiple ...
AbbVie ABBV-1.49%decrease; red down pointing triangle has struck a deal with generic drugmakers aimed at extending patent protection for its blockbuster autoimmune drug Rinvoq well into the next ...
AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback